The results showed that both clinical symptoms (daytime symptoms, nighttime symptoms, need o using reliever medicators) and spirometric values (VC, FVC, FEV1, PEF) have been ameliorated after 2 - week administration of ICS and continued to ameliorate over a period of 3 months treating with ICS.